Alexander Light

After a great ST3 year with @imperialurology, I'm very excited to start a 3 year @NIHRresearch Doctoral Fellowship with @IP_London! My PhD will focus on improving the diagnostic and therapeutic strategies for locally recurrent prostate cancer 🚀 @LondonProstate1 @TaimurShah

Wrapping up the session is @Reddy4Urology with the outcomes of 1379 men undergoing #FocalTherapy with #HIFU 🦾

Great to see one of our Chairs of Urology @Heer_Lab on the cover of the latest Urology Matters @TUF_tweets! Discussions about #TRANSFORM, his research programme at @imperialcollege and role as Chair of the Scientific and Education Committee at @TUF_tweets

🚨 SAVE THE DATE: 12th December 2025 📍 Hammersmith, London The Imperial Experimental Cancer Medicine Centre (ECMC) is hosting a one-day masterclass designed for early-career researchers in surgery and interventional sciences 🔗 Register now! tickettailor.com/events/imperia…

NEW PAPER in @bmj_latest "Dealing with continuous variables and modelling non-linear associations in healthcare data: practical guide" --> bmj.com/content/390/bm… #methodologymatters

🚨What's in a name? Why differentiation between biochemical recurrence and metastatic #prostatecancer matters 👏 New review led by @AnaelRizzo @dgsomucla & @PKanaburMD @UclaUrology 👉Differentiating BCR & metastatic risk groups is 🔑 to help personalize care for our patients…

The protocol paper for the #IP7PACIFIC RCT is now available online! This trial led by our group and funded by @CR_UK will provide definitive evidence for "fast" biparametric MRI and image-fusion biopsy using a novel trial design 🚨 @NikhilMayor sciencedirect.com/science/articl…

Great news! The IP7-PACIFIC Protocol paper has been published 😍 take a look... 👀 sciencedirect.com/science/articl… @IP_London @jonathananing @bui_nbt @ResearchNBT @rjcousins4 @MartaCobos1984

Learn more about the team of researchers leading TRANSFORM, the @ProstateUK-funded £42 million trial to find the best way to screen for #ProstateCancer 🔗prostatecanceruk.org/research/for-r…

Great to see our PhD student @NikhilMayor present the #TRANSFORM trial at tonight’s @Uroweb UROwebinar: The role of MRI in prostate cancer screening and diagnosis Recruitment to start later this year! @LondonProstate1 @ProstateUK

Finishing up #BAUS25 on the main stage our Clinical Lecturer @Connor_Urol presenting an update on two major UK prostate randomised controlled trial published this year #TRANSLATE #NEUROSAFE

Congratulations to the #IP2ATLANTA trials team on their presentation being selected for best of #BAUS25 @LondonProstate1 @Connor_Urol

[4/8] 🦆The TRANSFORM team @NikhilMayor @Fran_Rawlins @AJWLight @philipmcnamee @IP_London @QMULSocialPsych helped supporters of all ages understand how we’re working to find the best way to screen men for #ProstateCancer. 🔗prostatecanceruk.org/research/trans…

Meanwhile! Back at in London, @Fran_Rawlins gave a brilliant presentation showcasing TRANSFORM at the @ImperialCTU Unit Meeting 2025 #prostatecancer #prostatescreening @ImperialSandC @ProstateUK @LondonProstate1

Fantastic overview of diagnostic and therapeutic strategies in radiorecurrent prostate cancer by @TaimurShah Key takeaways - MRI highly sensitive for local disease (even more so with PSMA PET/CT) & focal therapy as effective as RP in the salvage setting #BAUS25

A superb turnout for our #BAUS25 Fun Run in collaboration with @TUF_tweets Massive 👏 to our volunteers and especially @SRHurology for her wonderful organisation, as per usual. Managed to avoid losing anyone en route, we think… @BAUSurology

Brilliant prostate cancer abstract session this morning with 4️⃣ presentations from Team IP at #BAUS25 Huge breadth covered including MRI diagnostics, focal therapy, intraoperative margin assessment, and cytoreduction strategies in metastatic disease

@NikhilMayor presents outcomes from the first prospective, blinded assessment of #FCM with the #HistologScanner in #RadicalProstatectomy #IP8FLUORESCE

Next up @cut_tt_chase presents the 5 year oncological outcomes of men with initial negative #ProstateCancer investigations in the #RAPID pathway 🏃

It’s a busy #ProstateCancer session at #BAUS25 - kicking off is @Connor_Urol with the outcomes from the #IP2ATLANTA pilot study 📊

Fantastic to see our FY1 Karen Gao present our data on Rezum for prostates >80mL. Take home - durable results with good patient satisfaction @lyanleung #BAUS25